Articles from XiFin

XiFin® Inc., a leading provider of revenue cycle management (RCM) solutions with embedded artificial intelligence (AI), will bring cutting-edge RCM innovation and actionable insights amidst ongoing industry change, to one of the industry’s most influential stages, speaking at four sessions at the 30th Annual Executive War College (EWC), taking place April 29-30 in New Orleans, LA. Doubling down on its focus on proven strategies and practical approaches in a time of uncertainty, XiFin will focus on prior authorization strategies that improve financial outcomes and digital automation tools that yield real-world improvements. Findings from the 2025 XiFin Payor Denial Impact Analysis will be available, alongside XiFin’s Empower Platform, Payor Rate Transparency Monitor, and Payor Intelligence Hub. To celebrate the milestone 30th EWC, a special Challenge will also be showcased.

XiFin, a leading provider of innovative healthcare revenue cycle management solutions that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, today previewed findings from its 2025 Pharmacy Transformation Outlook Survey, which highlights the growing role of pharmacists and the increasing interest in achieving operational efficiency through new technology and expanding pharmacy offerings via value-based care and specialty pharmacy. Alongside the findings and in advance of National Pharmacist Day on January 12, XiFin announced its CareALERTS™ smart clinical messaging technology successfully drove additional vaccinations in 2024.

This American Pharmacists Month, XiFin Pharmacy Solutions invites pharmacy professionals to participate in the 2025 Pharmacy Transformation Study aimed at uncovering critical success factors that will shape the future of pharmacy care. As evidence mounts regarding the increasing impact of pharmacists on health outcomes, this survey builds on the findings of the 2024 Pharmacy Transformation Study conducted by XiFin Pharmacy Solutions. It seeks to explore how pharmacists are bridging primary care gaps and transforming pharmacies into essential health and wellness hubs, especially in underserved areas. For instance, by using new alerting technology, participating pharmacies successfully increased companion pneumococcal immunizations by 28%, a notable increase considering, during the 2021-2022 influenza season, only about 49.4% of US adults were vaccinated against the flu. The 2025 survey seeks to understand the opportunities and gaps that exist as pharmacists expand their services.

OmniSYS, the pharmacy division of XiFin, Inc., announced its 2023 end-of-year CareALERTS™ data, demonstrating how pharmacists as providers are closing healthcare gaps at the point of care. CareALERTS was developed to increase immunization rates among adults and seniors, and in 2023 it successfully increased companion pneumococcal immunizations by 28% among participating pharmacies. This helped patients avoid preventable disease and unnecessary hospitalizations, reducing healthcare expenditures. OmniSYS released this data on National Pharmacist Day to celebrate pharmacists and urges all U.S. states to recognize pharmacists as providers of clinical services who can help address physician shortages and improve healthcare access for the nation’s most vulnerable and underserved communities.

In a letter to the chairs and ranking members of the House Energy and Commerce Committee and Health Subcommittee, XiFin CEO Lâle White urged policymakers to prioritize the Saving Access to Laboratory Services Act (SALSA) to set Medicare payments for clinical laboratory services on a stable and sustainable pathway. White’s appeal supports the position of the American Clinical Laboratory Association (ACLA), which led a Congressional appeal to drive a one-year delay in Protecting Access to Medicare Act (PAMA) reductions and data reporting included the recent short-term spending package.

Users of hospital/electronic health record (EHR)-based laboratory information systems (LIS) are increasingly dissatisfied and concerned about their current system's ability to keep up with future growth, according to a recent survey featured in the State of the Laboratory Information Systems Industry: Trends in Satisfaction, Reliability, Interoperability, and Security. Findings also corroborate renewed interest in digital pathology, revealing that over 40% of respondents use or plan to add digital pathology capabilities in the next 12 months. The free report is the latest in a series published by XiFin, a leading provider of innovative technologies and services that deliver operational efficiency, interoperability, and simplicity to the healthcare industry.

XiFin, a leading provider of innovative healthcare information technologies and services that deliver AI-enabled operational efficiency, interoperability, and simplicity, announced today that it has been named to Inc. 5000, Inc. Magazine’s annual ranking of the 5,000 fastest-growing private companies in America for a thirteenth time – a feat only 25 companies have accomplished since the award’s inception. The Inc. 5000 award is recognition of XiFin’s industry leadership in revenue cycle management (RCM) and workflow automation and of the company’s revenue growth of 157% over three years.

XiFin, a leading provider of innovative technologies and services that deliver operational efficiency, interoperability, and simplicity, announced today that it has earned Top Workplaces 2023: USA and Top Workplaces 2023: Healthcare Industry from Energage, the research company with more than 17 years of experience surveying over 27 million employees at 70,000 organizations. Based solely on employee feedback, these two awards follow XiFin’s earlier recognition as a Top Workplaces for Cultural Excellence 2022: Woman-Led Business, which celebrates outstanding organizations whose most senior leader is a woman and have built outstanding employee-focused workplace cultures that perform.

XiFin received the top customer and user satisfaction scores in nine of 18 revenue cycle management (RCM) services key performance indicators and outscored 19 competitors to rank #1 overall in Black Book Market Research surveys of 2,663 healthcare and medical users of RCM solutions for laboratories, radiology, and outpatient service providers and other ancillaries. XiFin outscored the nearest competitor with three times the number of top scores (nine #1 rankings vs. three #1 rankings).

Today XIFIN launches XIFIN RPM 15, the latest version of its industry-leading revenue cycle management platform that has earned certified status for information security by HITRUST. With the latest RCM investments, XIFIN aims to address four key market challenges: enhanced risk mitigation, payor accountability for price transparency, enhanced automation to offset staffing shortages and diagnostic specific industry benchmarks.

XIFIN today announced the results of a first-of-its-kind study that explored health leaders’ practices, attitudes, outcomes and satisfaction levels related to outsourcing revenue cycle management for outpatient service. The study, “An Analysis of Outpatient Revenue Cycle Management Outsourcing,” was conducted by the Healthcare Financial Management Association (HFMA) and demonstrates a growing interest in and opportunity to digitally transform outpatient RCM to improve efficiencies, optimize revenue and alleviate a growing administrative burden.

XIFIN announced today that John Kelly has joined the company as chief information officer. In this role, a first for the company, Kelly will advance product and service cohesion and operations as XIFIN integrates its recent corporate acquisitions and continues its growth trajectory.

At the 2022 Executive War College Conference on Laboratory and Pathology Management in New Orleans this week, XIFIN’s executive chairman and CEO Lâle White will present a keynote: “Consumers, Retail Pharmacies, and Big Data: New Market Dynamics Poised to Reshape Who Orders and Pays for Clinical Lab Services and Genetic Tests.”

XIFIN has partnered with NCODA, Inc., a globally recognized association that develops unique resources to help medically integrated oncology teams deliver top-tier care. This new strategic partnership “NCODA Informatics Initiative Powered by VisualStrata” provides use of VisualStrata as part of the NCODA membership. As oncology groups work to find and secure clinical trials – thereby expanding patient care options within their practice – purpose-built solutions are needed to enhance the data from their existing electronic health record (EHR) or practice management system (PMS). The partnership will enable NCODA members to integrate and curate siloed patient-centric data from disparate systems into a single unified view for their practice. Enterprise healthcare informatics solutions have previously been financially out of reach for many oncology practices. This initiative provides economies of scale and will help bridge the gap between oncology practices, genomic testing providers, and pharmaceutical stakeholders via a common cause, expanding patient options via clinical trial participation.

A new survey from XIFIN found a significant opportunity remains for diagnostic laboratories to improve the functionality and security of their laboratory information system (LIS). Notably, more than 30% of respondents indicated that their LIS had gaps in its ability to meet their testing needs – a significant problem, considering the nation is moving to an endemic approach to infectious disease, which will continue to drive testing, along with increasing genetic testing demands. Achieving operational efficiencies throughout the lab is an important requirement for diagnostic providers, requiring an LIS infrastructure that is functional, reliable, interoperable, and highly secure.

In 2021, XIFIN took significant steps to expand its support for customers nationwide through entry into new markets and regions, and ongoing innovation of its award-winning revenue cycle management (RCM) and laboratory information system (LIS) solutions. As a result of these accomplishments, XIFIN is positioned to open up a new “front door” to diagnostic providers – facilitating communication and data exchange through the retail pharmacy ecosystem, driving even greater patient access to healthcare information.

XIFIN today announced the strategic acquisition of OmniSYS, a leading provider of technology solutions for the retail pharmacy industry. Building on the acquisition of Computerized Management Services in July 2021, this transaction further expands on XIFIN’s role as a top provider of solutions and services that streamline and optimize the billing and claims process, provide healthcare leaders with greater business visibility, and support patient engagement. Together, XIFIN and OmniSYS will support retail pharmacies as they transition to a clinical services business model, drive closer relationships between pharmacies and diagnostic providers, and bring together complementary clinical and financial information via integrated cloud-based technology.

XIFIN today launched a new version of its award-winning revenue cycle management (RCM) system, XIFIN RPM 14. With this latest iteration of the company’s flagship RCM solution, XIFIN aims to address three key market challenges: improve information-sharing between patients, providers and labs; support the demand for price transparency; and ensure adequate billing expertise and resources where they’re most needed.

XIFIN today announced it has been named the #1 vendor for Laboratory Support and Revenue Cycle Management (RCM) in the latest survey on healthcare outsourcing conducted by Black Book Research. This marks the fifth time the company has been included in Black Book’s rankings and the second consecutive time it has been awarded this specific accolade. XIFIN has more than 20 years’ experience partnering with hospital-based and independent laboratories, imaging centers, pathology practices, and other diagnostic providers to optimize billing and claims processing via its award-winning XIFIN RPM solution in a flexible, outsourced model.

XIFIN, today introduced the newest iteration of its cloud-based laboratory information system (LIS), XIFIN LIS 8, demonstrating the company’s continued investment in improving operational, clinical and financial outcomes for diagnostic providers. New feature development for XIFIN LIS 8 is continually informed by customer and market input. Recently XIFIN conducted a survey with responses representing approximately 100 U.S.-based labs. Results revealed their key needs, including digital transformation and better testing support. Informed by these findings, XIFIN LIS 8 offers improved scalability, an enhanced role-based user experience, additional interface and configurability capabilities, digital pathology interoperability, and new document storage functionality that supports laboratory report sharing through the XIFIN patient portal.

In an upcoming Healthcare Financial Management Association (HFMA) member webinar, industry experts Jane Hermansen, Manager, Outreach and Network Development at Mayo Clinic Laboratories, and Emily Adams, Director of Outpatient Laboratory at Mount Carmel Health System, will join Mike Fauver, Associate Vice President of Health Systems at XIFIN, to discuss proven strategies that can transform labs from expense-driven environments into profit centers. During this September 14 webinar, these experts will explore current roadblocks, initiatives and tools for organizational success that attendees can apply to their own operational strategies.

XIFIN today announced it has been named to the Inc. 5000, Inc. Magazine’s annual ranking of the 5,000 fastest-growing private companies in America. During a period of unprecedented challenges for the healthcare industry and a significant shift towards telehealth, XIFIN proved able to not only meet the technological demands of diagnostic providers facing enormous testing volume surges, but also grew its revenue by 60% in just three years. As a twelve-time honoree, XIFIN joins an exclusive list of the nation's most successful private companies, including Intuit, Zappos, Oracle and Microsoft.

XIFIN today announced the acquisition of Computerized Management Services (CMS), a provider of revenue cycle management (RCM) services for radiology groups and imaging centers. This acquisition builds on XIFIN’s RCM leadership and footprint across the diagnostic industry, providing healthcare organizations with specialized solutions and services that streamline and optimize the billing process, improve claims management, and provide leaders with greater business visibility. The combined organization will provide robust healthcare technology services across diagnostic markets — including radiology, pathology, oncology, digital health, and laboratory.

In an upcoming Healthcare Financial Management Association (HFMA) member webinar, XIFIN Executive Chairman and CEO Lâle White and Kyle Fetter, recently promoted to chief operating officer at XIFIN, will discuss the growing importance of outpatient services and how healthcare organizations can optimize revenue. They will be joined by HFMA’s Head of Research Bill Voegeli who will discuss recent HFMA research findings on changing healthcare priorities, reimbursement models, and technology trends.